Capsule · The news app for modern leaders

Trends and Insights

Download
1 Jan 2024

Pfizer Revenue Dips as COVID Vaccine Demand Drops

content from a screenshot

After a peak of $28bn, Pfizer's last quarter's revenue fell to $13bn, [down 54%](https://www.chartr.co/newsletters/2023-12-15). Expecting a further drop to $8bn for COVID shots in 2024, they've lost 7% in shares, hitting a 10-year market cap low at $147bn. Cost-cutting measures include laying off 2,000 workers and a $43bn acquisition of Seagen Inc. to offset declining vaccine sales.